- Bank With Citibank? You’re About to Pay a Lot More
- FTC: ‘Free’ Products Aren’t Free
- Are You Wasting Your Money Buying Organic Food?
- Apple Pay Begins: What You Need to Know
- How to Avoid Getting the Flu (or Worse) On an Airplane
- Liar Labels: Is That Farmers Market Food Really Local?
- The Restless Project: She Has a Good Job, but Will She Have to Leave New Orleans?
- HBO Without Cable: It’s Planning a Stand-Alone Service
The Boston Globe has a report on the case of the Reckis family, whose daughter Samantha suffered a severe allergic reaction to Children’s Motrin (the pain reliever, ibuprofen) a decade ago.
She’s now 17, legally blind, and unable to walk more than the length of a football field without becoming physically exhausted. But she’ll now likely receive $50 million (and each of her parents, $6.5 million) from Johnson & Johnson, the company who made the product.
A jury recently found the company didn’t properly warn about potential side effects on the over-the-counter version, and was therefore responsible for Reckis’ Toxic Epidermal Necrolysis. It’s a rare, but often deadly or permanently damaging, reaction to certain medications.
According to the article, the verdict must be upheld by a trial judge. If it is, and interest from the lengthy delay is included, the award could be worth over $100 million.